Odobren lijek za rak gušterače!
One day3 outlets reported this in 6 reports over 1 day - a further 3 reports reprinted copy already published elsewhere
All 6 reports on Wed, 26 August 2026
What it is about
Who published it, and when
original reportcopyfirst to report
N1 Info (Croatia)
Index.hr (Croatia)
Vecernji list (Croatia)
Nacional (Croatia)
tportal (Croatia)
26 Aug, 19:43over 1 hour26 Aug, 20:10
1 report left out of the cascade - too little in common with the story to place
How it spread - 3 original reports, 3 reprints
Wed, 26 August 2026
3 reports- N1 Info (Croatia)19:43first to report
Američka Uprava za hranu i lijekove (FDA) odobrila je revolucionarni lijek za rak gušterače tvrtke Revolution Medicines nakon što se u velikom kliničk
2 reprints
- Nacional (Croatia)26 Aug, 20:00their copy
- tportal (Croatia)26 Aug, 20:10their copy
- Index.hr (Croatia)19:45
FDA JE ODOBRILA Rasonque, novi lijek koji udvostručuje stopu preživljavanja u uznapredovaloj fazi raka gušterače.
1 reprint
- Telegram.hr (Croatia)26 Aug, 19:54their copy
- Vecernji list (Croatia)19:51
Tableta koja se uzima jednom na dan, a nosit će naziv Rasonque, odobrena je za metastatski rak gušterače kod pacijenata koji su prethodno primali terapiju ili ne mogu primati kombiniranu kemoterapiju. Lijek je osmišljen kako bi blokirao nekoliko oblika proteina RAS, koji potiče rast tumora kod mnogih oblika raka gušterače.